Evaluation of human and mosquito based diagnostic tools for defining endpoints for elimination of Anopheles transmitted lymphatic filariasis in Ghana.

BACKGROUND The decision to stop mass drug administration (MDA) and monitor recrudescence has to be made when endpoints for elimination of lymphatic filariasis (LF) have been achieved. Highly sensitive and specific diagnostic tools are required to do this. The main objective of this study was to determine most effective diagnostic tools for assessing interruption of LF transmission. METHODS The presence of filarial infection in blood and mosquito samples was determined using five diagnostic tools: Brugia malayi-14 (BM14) antibody detection ELISA, Onchocerca gibsoni antigen (Og4C3) based ELISA, PCR, immunochromatography (ICT) card test and blood smear. The study was carried out in two communities in the Central Region of Ghana. RESULTS OG4C3 was found to be the most sensitive test but ICT, the second most sensitive, was the most field applicable. PCR was found to be the most specific. Thirteen out of 30 pools of anopheles mosquitoes tested positive for the DNA of Wuchereria bancrofti. CONCLUSIONS Very low antigen prevalence in primary school children indicates that MDA is working, so children born since the intervention was put in place are not getting infected. Inclusion of xenomonitoring in monitoring the effectiveness of MDA will give a better indication as to when transmission has been interrupted especially in areas where microfilaria prevalence is lower than 1%.

[1]  M. Rebollo,et al.  Elimination of Lymphatic Filariasis in The Gambia , 2015, PLoS neglected tropical diseases.

[2]  M. Rebollo,et al.  Shrinking the lymphatic filariasis map: update on diagnostic tools for mapping and transmission monitoring , 2014, Parasitology.

[3]  N. Alexander,et al.  Evaluation of diagnostic tests for Wuchereria bancrofti infection in Brazilian schoolchildren. , 2014, Revista da Sociedade Brasileira de Medicina Tropical.

[4]  R. Rao,et al.  Transmission Assessment Surveys (TAS) to Define Endpoints for Lymphatic Filariasis Mass Drug Administration: A Multicenter Evaluation , 2013, PLoS neglected tropical diseases.

[5]  P. Graves,et al.  Community-wide distribution of long-lasting insecticidal nets can halt transmission of lymphatic filariasis in southeastern Nigeria. , 2013, The American journal of tropical medicine and hygiene.

[6]  Margaret Chan,et al.  Sustaining the drive to overcome the global impact of neglected tropical diseases : second WHO report on neglected tropical diseases , 2013 .

[7]  Steven A. Williams,et al.  A Multicenter Evaluation of Diagnostic Tools to Define Endpoints for Programs to Eliminate Bancroftian Filariasis , 2012, PLoS neglected tropical diseases.

[8]  A. Dorkenoo,et al.  A laboratory-based surveillance system for Wuchereria bancrofti in Togo: a practical model for resource-poor settings. , 2011, The American journal of tropical medicine and hygiene.

[9]  David H. Molyneux,et al.  Filaria control and elimination: diagnostic, monitoring and surveillance needs. , 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[10]  M. Bockarie,et al.  Role of vector control in the global program to eliminate lymphatic filariasis. , 2009, Annual review of entomology.

[11]  M. Alpers,et al.  Mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea: changes in microfilaremia, filarial antigen, and Bm14 antibody after cessation. , 2008, The American journal of tropical medicine and hygiene.

[12]  Rosanna W. Peeling,et al.  Evaluation of diagnostic tests for infectious diseases: general principles , 2006, Nature Reviews Microbiology.

[13]  Fengfei Wang,et al.  Confirmation of elimination of lymphatic filariasis by an IgG4 enzyme-linked immunosorbent assay with urine samples in Yongjia, Zhejiang Province and Gaoan, Jiangxi Province, People's Republic of China. , 2007, The American journal of tropical medicine and hygiene.

[14]  D. Durrheim,et al.  Understanding the community impact of lymphatic filariasis: a review of the sociocultural literature. , 2007, Bulletin of the World Health Organization.

[15]  D. Addiss,et al.  Endpoints for Lymphatic Filariasis Programs , 2007, Emerging infectious diseases.

[16]  Gary J Weil,et al.  Diagnostic tools for filariasis elimination programs. , 2007, Trends in parasitology.

[17]  N. Twum-Danso,et al.  Editorial: Global elimination of lymphatic filariasis: fact or fantasy? , 2006, Tropical medicine & international health : TM & IH.

[18]  J. Gyapong,et al.  Treatment strategies underpinning the global programme to eliminate lymphatic filariasis , 2005, Expert opinion on pharmacotherapy.

[19]  D. Addiss Global elimination of lymphatic filariasis: origins, progress and challenges , 2005 .

[20]  E. Liebau,et al.  PCR-based detection and identification of the filarial parasite Brugia timori from Alor Island, Indonesia. , 2002, Annals of tropical medicine and parasitology.

[21]  R. Ramzy Field application of PCR-based assays for monitoring Wuchereria bancrofti infection in Africa. , 2002, Annals of tropical medicine and parasitology.

[22]  A. Hightower,et al.  Clearance of Wuchereria bancrofti antigen after treatment with diethylcarbamazine or ivermectin. , 1997, The American journal of tropical medicine and hygiene.

[23]  S. Adjei,et al.  Descriptive epidemiology of lymphatic filariasis in Ghana. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[24]  A. Hightower,et al.  Age-specific prevalence of antigenemia in a Wuchereria bancrofti-exposed population. , 1994, The American journal of tropical medicine and hygiene.